Celldex Therapeutics Inc (CLDX)
10.30
+0.10 +0.98%
NASDAQ
Aug 13, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 4.397M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.62 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -45.52M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -4.67K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 403.00M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 41.72 |
| PE Ratio | -- |
| Price to Book Value | 1.690 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -12.13M |
| Return on Equity | Upgrade |
View All CLDX News
News
-
WireHeadlineTime (ET)
-
MT Newswires08/06 16:10
-
Globe Newswire08/06 16:01
-
Globe Newswire08/03 08:01
-
Yahoo07/29 12:33
-
Yahoo07/09 11:01
-
Yahoo07/08 07:32
-
MT Newswires07/01 15:26
-
SA Breaking News06/22 11:02
-
MT Newswires06/19 12:28
-
SA Breaking News06/19 11:10
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/06/2021 | Misc | Celldex Therapeutics Inc Second Quarter Earnings Conference Call for 2021 |
| 11/12/2020 | Earnings | Celldex Therapeutics Inc Third Quarter Earnings Results for 2020 |
| 08/06/2020 16:30 EDT | Misc | Celldex Therapeutics Inc Second Quarter Earnings Conference Call for 2020 |
| 08/06/2020 | Earnings | Celldex Therapeutics Inc Second Quarter Earnings Result for 2020 |
| 06/18/2020 09:00 EDT | Misc | Celldex Therapeutics Inc Annual General Meeting for 2019 |
| 05/06/2020 | Earnings | Celldex Therapeutics Inc First Quarter Earnings Results for 2020 |
| 03/26/2020 | Earnings | Celldex Therapeutics Inc Fourth Quarter Earnings Results for 2019 |
| 03/26/2020 | Misc | Celldex Therapeutics Inc Annual Report for 2019 |
| 11/12/2019 | Earnings | Celldex Therapeutics Inc Third Quarter Earnings Results for 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.celldex.com
- Investor Relations URL: http://ir.celldex.com/index.cfm
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Nov. 12, 2020
- Last Earnings Release: Aug. 06, 2020
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 10.30 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| KRXCX | Kinetics Medical Adv C | 0.02% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CLDX Tweets Stocktwits
Advertisement
